Similar Posts
UK Patients Used as Drug ‘Guinea Pigs" Guardian
UK Patients Used as Drug ‘Guinea Pigs”_Guardian Feb 9 2003 Medical fraud experts in the U.K. estimate that one per cent of all drug trials involve fraud, including failure to get proper consent from patients. An investigation by The Guardian / Observer (UK) found widespread abuse by doctors who use…
1997 U.S. Government Experiments Violate Ethical Research Standards
The Declaration of Helsinki defines ethical research: “In any medical study, every patient – including those of a control group, if any – should be assured of the best proven diagnostic and therapeutic method.” (1964; 1996) That standard for ethical research was reaffirmed by the World Medical Association in 2000:…
FDA Internal Document: Use of Placebo-Controls in Life Threatening Diseases
The efficacy and safety of a new drug that treats a serious and life threatening illness in premature infants will be studied versus sham/placebo in Latin America. The sponsor plans to apply for FDA approval, in addition to local and European registration. There are approved therapies (surfactants) for this illness (Respiratory Distress Syndrome, or RDS) in those countries where this trial is proposed to take place, and surfactants are even used in some of their hospitals. However, surfactants are completely unavailable to infants at many other hospitals, secondary to rationing or economic limitations.
Chief Respiratory Care Mass General Hospital-Harvard-Rejects ARDS Recommendation
A critical editorial by Dr. Robert M Kacmarek, Head of Respiratory Care Services at Massachusetts General Hospital and professor at Harvard University—the coordinating center for the ARDS Network, calls into question the validity of the ARDS Network recommendation of treating all patients with ALI-ARDS with a fixed, low air ventilation setting (6 mL/ kg).
Poison Chalice–TGN1412_Sunday Times UK
All six healthy volunteers near death from catastrophic experiment–TGN1412.
Yale Psychiatric Institute, PRIME clinic
Disease mongering: " This program has been developed for people who, while in the prime of their lives, are at high risk for developing a debilitating mental illness."